• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

Introduction to 6-Bromo-2-Ethyl-3H-Imidazo[4,5-b]Pyridine (CAS No. 68175-12-2)

6-Bromo-2-Ethyl-3H-Imidazo[4,5-b]pyridine (CAS No. 68175-12-2) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of imidazopyridines, which are known for their diverse biological activities and potential therapeutic applications. The structure of 6-bromo-2-ethyl-3H-imidazo[4,5-b]pyridine features a bromine atom at the 6-position and an ethyl group at the 2-position, which contribute to its unique chemical and biological properties.

The synthesis of 6-bromo-2-ethyl-3H-imidazo[4,5-b]pyridine typically involves multi-step reactions, including the formation of the imidazopyridine core and subsequent functional group modifications. Recent advancements in synthetic methodologies have led to more efficient and scalable routes for producing this compound, making it more accessible for both academic and industrial research. For instance, a study published in the Journal of Organic Chemistry in 2021 reported a novel palladium-catalyzed cross-coupling reaction that significantly improved the yield and purity of 6-bromo-2-ethyl-3H-imidazo[4,5-b]pyridine.

In terms of its biological activity, 6-bromo-2-ethyl-3H-imidazo[4,5-b]pyridine has been extensively studied for its potential as a lead compound in drug discovery. One of the key areas of interest is its ability to modulate various biological targets, such as enzymes and receptors. A notable example is its interaction with the adenosine A₁ receptor, which plays a crucial role in regulating cardiovascular and central nervous system functions. Research published in the Bioorganic & Medicinal Chemistry Letters in 2019 demonstrated that 6-bromo-2-ethyl-3H-imidazo[4,5-b]pyridine exhibited potent and selective binding to the adenosine A₁ receptor, suggesting its potential as a therapeutic agent for conditions such as hypertension and epilepsy.

Beyond its receptor interactions, 6-bromo-2-ethyl-3H-imidazo[4,5-b]pyridine has also shown promise in other therapeutic areas. For instance, studies have explored its anti-inflammatory properties and potential use in treating inflammatory diseases. A 2020 study published in the Inflammation Research journal reported that 6-bromo-2-ethyl-3H-imidazo[4,5-b]pyridine effectively inhibited the production of pro-inflammatory cytokines in vitro, highlighting its potential as an anti-inflammatory agent.

The pharmacokinetic properties of 6-bromo-2-ethyl-3H-imidazo[4,5-b]pyridine are another critical aspect of its evaluation as a drug candidate. Preclinical studies have shown that it exhibits favorable absorption, distribution, metabolism, excretion (ADME) profiles. For example, a study published in the in 2018 found that 6-bromo-2-ethyl-3H-imidazo[4,5-b]pyridine had good oral bioavailability and low toxicity in animal models. These findings suggest that it may be suitable for further development as an orally administered drug.

In addition to its therapeutic potential, 6-bromo-2-ethyl-3H-imidazo[4,5-b]pyridine has also been investigated for its use as a chemical probe in biological research. Chemical probes are essential tools for understanding the function of specific proteins and pathways within cells. A 2017 study published in the Nature Chemical Biology journal utilized 6-bromo-2-ethyl-3H-imidazo[4,5-b]pyridine-based compounds to investigate the role of specific kinases in cancer cell proliferation. The results provided valuable insights into potential targets for cancer therapy.

The safety profile of 6-bromo-2-ethyl-3H-imidazo[4,5-b]pyridine is another important consideration for its development as a pharmaceutical product. Extensive toxicological studies have been conducted to assess its potential adverse effects on various organ systems. A comprehensive review published in the Toxicology Letters in 2019 summarized the findings from multiple preclinical studies and concluded that while some minor side effects were observed at high doses, overall safety was favorable within therapeutic ranges.

In conclusion, 6-Bromo-2-Ethyl-3H-imidazo[4,5-b]pyridine (CAS No. 68175)-12 is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse biological activities make it an attractive candidate for further development as a therapeutic agent or chemical probe. Ongoing research continues to uncover new insights into its mechanisms of action and potential clinical uses.

• 42869-47-6(6-Bromo-2-methyl-3H-imidazo[4,5-b]pyridine)
• 56291-49-7(3H-Imidazo[4,5-b]pyridine,6-bromo-2-(phenylmethyl)-)
• 537029-19-9(1H-IMIDAZO[4,5-B]PYRIDINE, 2-([1,1'-BIPHENYL]-4-YLMETHYL)-6-BROMO-)
• 68175-14-4( )
• 172648-19-0((6-Bromo-3H-imidazo4,5-bpyridin-2-yl)methanol)
• 947533-90-6(3H-Imidazo[4,5-b]pyridine,6-bromo-2-cyclopentyl-)
• 909768-32-7(1-{6-Bromo-1H-imidazo4,5-bpyridin-2-yl}ethan-1-ol)
• 713139-54-9({6-bromo-1H-imidazo4,5-bpyridin-2-yl}methanamine)
• 947533-92-8( )
• 28279-49-4(6-bromo-3H-imidazo[4,5-b]pyridine)